The second-generation tyrosine kinase inhibitor afatinib inhibits IL-1β secretion via blocking assembly of NLRP3 inflammasome independent of epidermal growth factor receptor signaling in macrophage
- Resource Type
- Article
- Source
- In
Molecular Immunology January 2023 153:135-145 - Subject
- Language
- ISSN
- 0161-5890